296 related articles for article (PubMed ID: 11040493)
1. [Skin manifestations of Lyme borreliosis in patients at the 1st Dermato-venereologic Clinic of Comenius University Medical School in Bratislava 1996-1998].
Svecová D; Buchvald J; Oprsalová K; Dolezalová A
Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):115-22. PubMed ID: 11040493
[TBL] [Abstract][Full Text] [Related]
2. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
[TBL] [Abstract][Full Text] [Related]
3. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
4. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
5. [Borrelia infections of the skin--progress of knowledge since the discovery of Lyme disease].
Garbe C
Hautarzt; 1991 Jun; 42(6):356-65. PubMed ID: 1917458
[TBL] [Abstract][Full Text] [Related]
6. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
7. Skin Changes in Suspected Lyme Disease.
Vržogić P; Perica A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
[TBL] [Abstract][Full Text] [Related]
8. Comparison of erythema migrans caused by Borrelia afzelii and Borrelia garinii.
Logar M; Ruzić-Sabljić E; Maraspin V; Lotric-Furlan S; Cimperman J; Jurca T; Strle F
Infection; 2004 Feb; 32(1):15-9. PubMed ID: 15007737
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia.
Ruzić-Sabljić E; Maraspin V; Lotric-Furlan S; Jurca T; Logar M; Pikelj-Pecnik A; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):544-50. PubMed ID: 12422599
[TBL] [Abstract][Full Text] [Related]
11. [Criteria for evaluation of immunoblots using Borrelia afzelii, Borrelia garinii and Borrelia burgdorferi sensu stricto for diagnosis of Lyme borreliosis].
Honegr K; Havlasová J; Gebouský P; Dostál V; Pellantová V; Skrabková Z; Hulínská D
Epidemiol Mikrobiol Imunol; 2001 Nov; 50(4):147-56. PubMed ID: 11769176
[TBL] [Abstract][Full Text] [Related]
12. [Dermatological aspects of Lyme borreliosis].
Lipsker D
Med Mal Infect; 2007; 37(7-8):540-7. PubMed ID: 17391884
[TBL] [Abstract][Full Text] [Related]
13. [Borrelia strains that cause erythema migrans in Alsace, France].
Antoni-Bach N; Jaulhac B; Hansmann Y; Limbach F; Lipsker D
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):15-8. PubMed ID: 11937923
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
[TBL] [Abstract][Full Text] [Related]
15. Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis.
Jones KL; Muellegger RR; Means TK; Lee M; Glickstein LJ; Damle N; Sikand VK; Luster AD; Steere AC
Clin Infect Dis; 2008 Jan; 46(1):85-92. PubMed ID: 18171218
[TBL] [Abstract][Full Text] [Related]
16. [Lymphocyte proliferation test in cutaneous manifestations of Lyme borreliosis].
Breier F; Klade H; Stanek G
Wien Med Wochenschr; 1995; 145(7-8):170-3. PubMed ID: 7610666
[TBL] [Abstract][Full Text] [Related]
17. [Culture of Borrelia burgdorferi sensu lato from patients in the Czech Republic].
Hulínská D; Drevová H; Godová T; Janovská D
Epidemiol Mikrobiol Imunol; 2001 Apr; 50(2):74-81. PubMed ID: 11329731
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic possibilities and limitations in Lyme borreliosis].
Satz N; Knoblauch M
Schweiz Med Wochenschr; 1989 Dec; 119(52):1883-93. PubMed ID: 2692151
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
Glatz M; Golestani M; Kerl H; Müllegger RR
Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
[TBL] [Abstract][Full Text] [Related]
20. [Tick borne zoonosis: selected clinical and diagnostic aspects].
Sambri V; Marangoni A; Storni E; Cavrini F; Moroni A; Sparacino M; Cevenini R
Parassitologia; 2004 Jun; 46(1-2):109-13. PubMed ID: 15305697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
